Remel, Inc. is recalling 139 units (approximately 13,900 tests) of its Todd Hewitt Broth w/CNA (LIM Broth), a specialized laboratory product used to isolate Group B Streptococci from patient clinical samples. The recall was initiated because one specific lot of the broth may fail to grow the target bacteria during quality control testing or when processing patient samples. This defect was identified during customer testing and could lead to inaccurate laboratory results.
If the broth fails to recover the target organism, it could result in a false-negative test for Group B Streptococci, potentially leading to a delay in diagnosis or improper treatment for patients.
Manufacturer notification and corrective action
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.